Terpenoid ID | TKC001930 | |
Chirality | TKC151881 | |
Cell line | 0 | |
Protein target | 8 | |
DiseaseNCIT | 0 | |
ORDO | 0 | |
ICD | 21 |
ID | Cell Line | Synonyms | Value | Unit | Type | NCIt | ORDO |
---|---|---|---|---|---|---|---|
TKC001930 | U-251 | U-251 MG; U-251-MG; U-251_MG; U251-MG; U251MG; U-251; U251; U251n; U251N; 251 MG; 251MG; 251 MG(6) | 81.0 | uM | IG50 | C60781 | Orphanet_94 |
TKC001930 | DU-145 | DU-145; Du-145; DU 145; DU_145; DU.145; Duke University 145 | 2.0 | uM | IG50 | C4863 | |
TKC001930 | HL-60 | HL 60; HL.60 HL60; Human Leukemia-60 | 25620.0 | nM | GI50 | C9154 | Orphanet_519 |
TKC001930 | A549 | 28.0 | uM | ED50 | C3512 | ||
TKC001930 | 5637 | 45.0 | % | Inhibition | C4912 | ||
TKC001930 | HeLa | HELA; Hela; He La; He-La; HeLa-CCL2; Henrietta Lacks cells; Helacyton gartleri | 149.0 | ug.mL-1 | IC50 | C27677 | |
TKC001930 | ACHN | 328.0 | ug.mL-1 | IC50 | C6975 | Orphanet_319298 | |
TKC001930 | B16 | B-16; B16 melanoma; B16 subline B78; B78 | 25.0 | ug.mL-1 | IC50 | C21790 | |
TKC001930 | P388 | P-388 | 35.0 | uM | ED50 | C21602 | |
TKC001930 | KB | KB (HeLa derivative); HeLa-KB; Strain KB | 5.0 | uM | ED50 | C27677 | |
TKC001930 | HT-29 | HT 29; HT29 | 29.0 | uM | ED50 | C4349 | |
TKC001930 | MCF7 | 19.0 | uM | ED50 | C4194 | ||
TKC001930 | HEK293 | 8.0 | uM | ED50 | |||
TKC001930 | NIH3T3 | NIH/3T3; NIH-3T3; NIH3T3; 3T3; 3T3NIH; 3T3-Swiss; Swiss-3T3; Swiss/3T3; Swiss 3T3; Swiss3T3 | 64270.0 | nM | IC50 | ||
TKC001930 | PC-12 | PC 12; PC12 | 19.0 | % | Activity | C5650 |
ID | Uniport | Pref_name | Gene name | value | unit | type |
---|---|---|---|---|---|---|
TKC001930 | Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | TDP1 | 29093 | nM | Potency |
TKC001930 | O43451 | Maltase-glucoamylase, intestinal | MGAM | 17 | % | Inhibition |
TKC001930 | Q03431 | Parathyroid hormone/parathyroid hormone-related peptide receptor | PTH1R | 50119 | nM | Potency |
TKC001930 | Q16236 | Nuclear factor erythroid 2-related factor 2 | NFE2L2 | 20596 | nM | Potency |
TKC001930 | O75164 | Lysine-specific demethylase 4A | KDM4A | 89125 | nM | Potency |
TKC001930 | P27695 | DNA-(apurinic or apyrimidinic site) endonuclease | APEX1 | 31623 | nM | Potency |
TKC001930 | Q962Y6 | Thioredoxin glutathione reductase | TGR | 39811 | nM | Potency |
TKC001930 | Q9UBT6 | DNA polymerase kappa | POLK | 89125 | nM | Potency |
TKC001930 | Q9UNA4 | DNA polymerase iota | POLI | 89125 | nM | Potency |
Uniport ID | Uniport Name | ICD-11 |
---|---|---|
O43451 | MGA_HUMAN | Acute diabete complication [ICD-11: 5A2Y] |
O43451 | MGA_HUMAN | Cardiovascular disease [ICD-11: BA00-BE2Z] |
O43451 | MGA_HUMAN | Inborn carbohydrate metabolism error [ICD-11: 5C51] |
O43451 | MGA_HUMAN | Muscle disorder [ICD-11: FB32-FB3Z] |
O43451 | MGA_HUMAN | Human immunodeficiency virus disease [ICD-11: 1C60-1C62] |
O43451 | MGA_HUMAN | Type 2 diabetes mellitus [ICD-11: 5A11] |
O43451 | MGA_HUMAN | Dengue fever [ICD-11: 1D2Z] |
O43451 | MGA_HUMAN | Blood chemistry clinical sympton [ICD-11: MA18] |
Q03431 | PTH1R_HUMAN | Low bone mass disorder [ICD-11: FB83] |
Q03431 | PTH1R_HUMAN | Hypo-parathyroidism [ICD-11: 5A50] |
Q16236 | NF2L2_HUMAN | Ataxic disorder [ICD-11: 8A03] |
Q16236 | NF2L2_HUMAN | Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 | NF2L2_HUMAN | Glaucoma [ICD-11: 9C61] |
Q16236 | NF2L2_HUMAN | Lung cancer [ICD-11: 2C25] |
Q16236 | NF2L2_HUMAN | Macular degeneration [ICD-11: 9B75] |
Q16236 | NF2L2_HUMAN | Melanoma [ICD-11: 2C30] |
Q16236 | NF2L2_HUMAN | Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 | NF2L2_HUMAN | Pulmonary hypertension [ICD-11: BB01] |
Q16236 | NF2L2_HUMAN | Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 | NF2L2_HUMAN | Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 | NF2L2_HUMAN | Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 | NF2L2_HUMAN | Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 | NF2L2_HUMAN | Motor neuron disease [ICD-11: 8B60] |
Q16236 | NF2L2_HUMAN | Multiple sclerosis [ICD-11: 8A40] |
P27695 | APEX1_HUMAN | Retinopathy [ICD-11: 9B71] |
P27695 | APEX1_HUMAN | Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 | APEX1_HUMAN | Ocular cancer [ICD-11: 2D00-2D07] |
P27695 | APEX1_HUMAN | Brain cancer [ICD-11: 2A00] |
P27695 | APEX1_HUMAN | Melanoma [ICD-11: 2C30] |